Barclays raised the firm’s price target on Kodiak Sciences (KOD) to $4 from $3 and keeps an Underweight rating on the shares. The firm says the company’s Q3 highlighted recent progress and provided update across key pipeline programs.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KOD: